CTI August 2021 Development Update

Development Update #8, from 11th July to August 20th 2021.

CTi-OEM

As you may already be aware, ClinTex announced the launch of CTi-OEM on August 3rd and we are proud to report that all beta stress tests have passed with flying colours.

Now that CTi-OEM initial testing has completed and all data quality and reconciliation issues have been addressed, we have begun building out CTi-OEM’s actual use case : to create real world clinical trial scenarios and review these from within CTi-OEM, whilst the platform is up and running and live.

CTi-OEM provides intuitive operational oversight of clinical trials for clinical project managers, clinical data managers and remote staff and is now available for prospective pharmaceutical partners to trial.

Interested parties are invited to contact us at industry@clintex.io for more information on becoming part of the pilot program.

CTi-PDA

Development of CTi-PDA has begun and we are currently focused on the development of “writebacks”, from visualisation software into the CTi Data Model. Writebacks will allow the storage of historical metrics, in order to drive predictive analytics for future reference as data points in studies and trials conducted using the CTi suite.

Website Re-Launch

As we touched on in our previous development update, ClinTex have undergone an update in our branding and we have overhauled our public facing image via a web-site redesign and updated YouTube promotional and informative videos. We also uploaded a series of explainer videos, demonstrating the CTi-OEM front app and dashboard, so head on over to our YouTube channel if you haven’t already checked that out :
https://youtube.com/c/ClintexCTI

We have also launched our sister website, targeted at pharmaceutical industry professionals — https://clinicaltrialsintelligence.org

While clintex.io remains home for the CTi token community, we will use clinicaltrialsintelligence.org to allow clinical trials and pharmaceutical professionals and organisations to interact with the CTi application suite. As stated above, if you represent an organisation or have a professional interest in becoming part of the pilot roll out, don’t hesitate to drop us a mail at industry@clintex.io

Staking Program Coming to a Close

Our staking program on KuCoin’s X-Pool completed successfully on 19th August 2021. You can still stake CTi on ClinTex’s own staking at portal here however you need to be quick as there is only 5 weeks remaining and after this time, all staking programs to obtain bonus free CTi tokens will cease.
This will mark the beginning of our ‘deflationary’ phase. Going forward, an important aspect of CTi tokenomics, defines that over time CTi tokens will be burned, the schematics of which are discussed in more detail in this article.

Next Sprint #9

The next sprint will delve into detail on our on-going development of CTi’s next application — CTi-PDA. We will discuss and explain our vision surrounding the power and potential of the application of Predictive Analytics on Clinical Trial efficiency.

About ClinTex

ClinTex are a solution provider to the pharmaceutical industry, and the team behind CTi — Clinical Trials Intelligence: a new type of software platform aimed at transforming the medicine development industry through the application of predictive analytics, machine learning, and the novel use of blockchain technology and smart contracts in clinical trials.

Our mission is to bring down the cost of medicine and improve the speed to market of new medicines for the people who need them, through vastly reducing development costs for the global pharmaceutical industry.

Follow Us:

Clinical Trials Intelligence is a data management software solution for the clinical trials industry that leverages distributed ledger technology